A neurotensin receptor antagonist inhibits acute immobilization stress- induced cardiac mast cell degranulation, a corticotropin-releasing hormone- dependent process

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 1, 1998, Pages 307-314

  Pang, Xinzhu ^a   Alexacos, Nicholas ^a   Letourneau, Richard ^a   Seretakis, Dimitri ^a   Gao, Wei ^a   Boucher, William ^a   Cochrane, David E ^b   Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; CORTICOTROPIN RELEASING FACTOR; CROMOGLYCATE DISODIUM; HISTAMINE; NEUROPEPTIDE; NEUROTENSIN; NEUROTENSIN RECEPTOR ANTAGONIST;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG MECHANISM; HEART ARREST; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; IMMOBILIZATION STRESS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAST CELL DEGRANULATION; MENTAL STRESS; MIGRAINE; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL COUNT; CELL DEGRANULATION; CORTICOTROPIN-RELEASING HORMONE; HISTAMINE; MALE; MAST CELLS; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTENSIN; STRESS, PSYCHOLOGICAL; SUBSTANCE P;

EID: 0032463960     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Al'Abadie MS, Kent GG and Gawkrodger DJ (1994) The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 130:199-203.
2. Alexander RW (1994) Inflammation and coronary artery disease. N Engl J Med 31:468-469.
3. Bakos P, Agelakas J, Letourneau EJ, Spanos P, Brophy CM, Spanos CP and Theoharides TC (1994) Increased number of activated mast cells at sites of abdominal aortic aneurysms. Int J Immunopathol Pharmacol 7:153-162.
4. Bankl HC, Radaszkiewicz T, Klappacher GW, Glogar D, Sperr WR, Grossschmidt K, Bankl H, Lechner K and Valent P (1995) Increase and redistribution of cardiac mast cells in auricular thrombosis: Possible role of kit ligand. Circulation 91:275-283.
5. Carraway R, Cochrane DE, Lansman JB, Leeman SE, Paterson BM and Welch HJ (1932) Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J Physiol 323:403-414.
6. Castagliuolo I, LaMont JT, Qiu B, Fleming SM, Bhaskar KR, Nikulasson ST, Kornetsky C and Pothoulakis C (1996) Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am J Physiol 271:884-892.
7. Castagliuolo I, Leeman SE, Bartolac-Suki E, Nikulasson S, Qiu B, Carraway RE and Pothoulakis C (1996) A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats. Proc Natl Acad Sci USA 93:12611-12615.
8. Christian EP, Undem BJ and Weinreich D (1989) Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro. J Physiol 409:297-312.
9. Chrousos GP (1995) The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 332:1351-1362.
10. Claman HN (1989) On scleroderma: mast cells, endothelial cells and fibroblasts. JAMA 262:1206-1209.
11. Cochrane DE, Carraway RE, Feldberg RS, Boucher W and Gelfand JM (1993) Stimulated rat mast cells generate histamine-releasing peptide from albumin. Peptides 14:117-123.
12. Constantinides P (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1083.
13. Criqui MH, Lee ER, Hamburger RN, Mauber MR and Coughlin SS (1987) IgE and cardiovascular disease: results from a population-based study. Am. J Med 82:964-968.
14. Deanfield JE, Shea M, Kensett M, Horlock P, Wilson RA, deLandsheere CM and Selwyn AP (1984) Silent myocardial ischaemia due to mental stress. Lancet 1:1001-1004.
15. Deedwania PC (1995) Mental stress, pain perception and risk of silent ischemia. JACC 25:1504-1506.
16. Fernex M (1961) Mast cells in the myocardium. Acta Trop 18:13.
17. Foreman JC (1987) Neuropeptides and the pathogenesis of allergy. Allergy 42:1-11.
18. Forman MB, Gates JA, Robertson D, Robertson RM, Roberts LJ II and Virmani R (1985) Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 313:1138-1141.
19. Freeman LJ, Nixon PGF, Sallabank P and Reaveley D (1987) Psychological stress and silent myocardial ischemia. Am Heart J 114:477-482.
20. Frieri M (1992) Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy 69:385-395.
21. Galli SJ (1993) New concepts about the mast cell. N Engl J Med 328:257-265.
22. Ginsburg R, Bristow MR and Davis K (1984) Receptor mechanisms in the human epicardial coronary artery. Heterogenous pharmacological response to histamine and carbachol. Circ Res 55:416-421.
23. Goetzl EJ, Cheng PPJ, Hassner A, Adelman DC, Frick OL and Speedharan SP (1990) Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Clin Exp Allergy 20:3-7.
24. Gottdiener JS, Krantz DS, Howell RH, Hecht GM, Klein J, Falconer JJ and Rozanski A (1994) Induction of silent myocardial ischemia with mental stress testing: relation to triggers of ischemia during daily life activities and to ischemic functional severity. J Am Coll Cardiol 24:1645-1651.
25. Gristwood RW, Lincoln JC, Owen DA and Smith IR (1981) Histamine release from human right atrium. Br J Pharmacol 74:7-9.
26. Hellstrom B and Holmgren H (1995) Numerical distribution of mast cells in the human skin and heart. Acta Anat 10:81-107.
27. Jain D, Burg M, Soufer R and Zaret BL (1995) Prognostic implications of mental stress-induced silent left ventricular dysfunction in patients with stable angina pectoris. Am J Cardiol 76:31-35.
28. Jenne DE and Tschopp J (1991) Angiotensin II-forming heart chymase is a mast-cell-specific enzyme. Biochem J 276:567.
29. Kaartinen M, Penttilä A and Kovanen PT (1994) Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90:1669-1678.
30. Karalis K, Louis JM, Bae D, Hilderbrand H and Majzoub JA (1997) CRH and the immune system. J Neuroimmunol 72:131-136.
31. Karalis K, Sano H, Redwine J, Listwak S, Wilder RL and Chrousos GP (1991) Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254:421-423.
32. Kolodgie FD, Virmani R, Cornhill JF, Herderick EE and Smialek J (1991) Increase in atherosclerosis and adventitial mast cells in cocaine abusers: An alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. JACC 17: 1553-1560.
33. Kovanen PT, Kaartinen M and Paavonen T (1995) Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084-1088.
34. Kruger PG, Aas P, Onarheim J and Helle KB (1982) Neurotensin-induced release of histamine from rat mast cells in vitro. Acta Physiol Scand 114:467-469.
35. Leor J, Poole WK and Kloner RA (1996) Sudden cardiac death triggered by an earthquake. N Engl J Med 334:413-419.
36. Letourneau R, Pang X, Sant GR and Theoharides TC (1996) Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 77:41-54.
37. Levi R and Burke JA (1980) Cardiac anaphylaxis: SRS-A potentiates and extends the effects of released histamine. Eur J Pharmacol 62:41-49.
38. Lichtbroun AS, Sandhaus LM, Giorno RC, Kim H and Seibold JR (1990) Myocardial mast cells in systemic sclerosis: a report of three fatal cases. Am J Med 89:372-376.
39. Lowman MA, Rees PH, Benyon RC and Church MK (1988) Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 81:590-597.
40. Marone G, Patella V, deCrescenzo G, Genovese A and Adt M (1995) Human heart mast cells in anaphylaxis and cardiovascular disease. Int Arch Allergy Immunol 107:72-75.
41. Marshall JS and Waserman S (1995) Mast cells and the nerves - potential interactions in the context of chronic disease. Clin Exp Allergy 25:102-110.
42. Mastorakos G, Bouzas EA, Silver PB, Sartani G, Friedman TC, Chan C-C, Caspi RR and Chrousos GP (1995) Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinis in rodents. Endocrinology 136:4650-4658.
43. Miller LA, Cochrane DE, Carraway RE and Feldberg RS (1995) Blockade of mast cell histamine secretion in response to neurotensin by SR 48692, a nonpeptide antagonist of the neurotensin brain receptor. Br J Pharmacol 114:1466-1470.
44. Nasr S, Altman EG and Meltzer HY (1981) Concordance of atopic and affective disorders. J Affective Disord 3:291-296.
45. Nisato D, Guiraudou P, Barthelemy G, Gully D and Le Furm G (1994) SR 48692, a non-peptide neurotensin receptor antagonist, blocks the cardiovascular effects elicited by neurotensin in guinea pigs. Life Sci 54:PL95-PL100.
46. Norvell N, Roth DL, Franco E and Pepine CJ (1989) Cardiovascular reactivity and silent ischemia in response to mental stress in symptomatic and asymptomatic coronary artery disease patients: results of a pilot study. Clin Cardiol 12:634-638.
47. Opgenorth TJ, Budzik GP, Mollison KW, Davidsen SK, Holst MR and Holleman WH (1990) Atrial peptides induce mast cell histamine release. Peptides 11:1003-1007.
48. Patella V, de Crescenzo G, Ciccarelli A, Marino I, Adt M and Marone G (1995) Human heart mast cells: A definitive case of mast cell heterogeneity. Int Arch Allergy Immunol 106:386-393.
49. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M and Marone G (1995) Human heart mast cells: isolation, purification, ultrastructure, and immunologic characterization. J Immunol 154:2855-2865.
50. Patella VP, Marino I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M and Marone G (1998) Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 97:971-978.
51. Pearce FL, Befus AD, Gauldie J and Bienenstock J (1982) Mucosal mast cells. II: Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol 128:2481-2486.
52. Pepine CJ (1996) Prognostic implications of silent myocardial ischemia. N Engl J Med 334:113-114.
53. Proctor GB, Chan K-M, Garrett JR and Smith RE (1991) Proteinase activities in bovine atrium and the possible role of mast cell tryptase in the processing of atrial natriuretic factor (ANF). Comp Biochem Physiol 998:839-844.
54. Quirion R, Rioux F, Regoli D and St-Pierre S (1980) Selective blockade of neurotensin-induced coronary vessel constriction in perfused rat hearts by a neurotensin analogue. Eur J Pharmacol 61:309-312.
55. Reinecke M, Weihe E, Carraway RE, Leeman SE and Forssmann WG (1982) Localization of neurotensin immunoreactive nerve fibers in the guinea-pig heart: evidence derived by immunohistochemistry, radioimmunoassay and chromatography. Neuroscience 7:1785-1795.
56. Ridker PM, Cushman M, Stampfer MJ, Tracy RP and Hennekens CH (1997) Inflammation, aspirin and the risk or cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979.
57. Rioux F, Kérouac R and St-Pierre S (1984) Neurotensin stimulates histamine release from the isolated, spontaneously beating heart of rats. Life Sci 35:423-431.
58. Roberts LJ (1984) Recurrent syncope due to systemic mastocytosis. Hypertension 6:285-294.
59. Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M, Hilton-Chalfen S, Hestrin L, Bietendorf J and Berman DS (1988) Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 318:1005-1012.
60. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seegar T, Seymour P, Tingley FD III, Winston EN, Chen YL and Heym J (1996) CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci 93:10477-10482.
61. Schwartz HJ, Yunginger JW and Schwartz LB (1995) Is unrecognized anaphylaxis a cause of sudden unexpected death? Clin Exp Allergy 25:866-870.
62. Specchia G, Falcone C, Traversi E, La Rovere MT, Guasti L, De Micheli G, Ardissino D and De Servi S (1991) Mental stress as a provocative test in patients with various clinical syndromes of coronary heart disease. Circulation 83:11-108-114.
63. Stead RH, Bienenstock J, Burger MM, Sordat B and Zinkernagel RM (1990) Cellular interactions between the immune and peripheral nervous system. A normal role for mast cells? in Cell to Cell Interaction, pp 170-187, Karger, Basel.
64. Stenzel P, Kesterson R, Yeung W, Cone RD, Rittenberg MB and Stenzel-Poore MP (1995) Identification of a novel murine receptor for corticotropin-releasing hormone expressed in the heart. Mol Endocrinol 9:637-645.
65. Sternfeld B, Stang P and Sidney S (1995) Relationship of migraine headaches to experience of chest pain and subsequent risk for myocardial infarction. Neurology 45:2135-2142.
66. Tainsh KR and Pearce FL (1992) Mast cell heterogeneity: evidence that mast cells isolated from various connective tissue locations in the rat display markedly graded phenotypes. Int Arch Allergy Immunol 98:26-34.
67. Theoharides TC (1990) Mast cells: the immune gate to the brain. Life Sci 46:607-617.
68. Theoharides TC (1996) Mast cell: a neuroimmunoendocrine master player. Int J Tissue React 18:1-21.
69. Theoharides TC, Sieghart W, Greengard P and Douglas WW (1980) Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science 207:80-82.
70. Theoharides TC, Singh L, Boucher W, Pang X, Letourneau R, Webster E and Chrousos G (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139:403-413.
71. Theoharides TC, Singh LK, Boucher W, Pang X Letourneau R, Webster E and Chrousos G (1998) Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects. Endocrinology 139:403-413.
72. Theoharides TC, Spanos CP, Pang X, Alferes L, Ligris K, Letourneau R, Rozniecki JJ, Webster E and Chrousos G (1995) Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology 136:5745-5750.
73. Trichopoulos D, Katsouyanni K, Zavitsanos X, Tzonou A and Dalla-Vorgia P (1983) Psychological stress and fatal heart attack: the Athens (1981) earthquake natural experiment. Lancet 1:441-443.
74. Williams RM, Bienenstock J and Stead RH (1995) Mast cells: The neuroimmune connection. Chem Immunol 61:208-235.